The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction

L Park1, G Wang1, J Moore1

  • 1Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, New York 10065, USA.

Nature Communications
|October 30, 2014
PubMed

Insights

Alzheimer's disease involves amyloid-beta (Aβ) damaging brain blood vessels. This study reveals Aβ causes DNA damage, activating TRPM2 channels, leading to impaired brain blood flow and dysfunction.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Cell Biology

Background:

  • Alzheimer's dementia affects over 35 million globally, characterized by amyloid-beta (Aβ) pathology.
  • Aβ-induced cerebrovascular dysfunction impairs oxygen and glucose delivery to the brain, contributing to dementia.
  • The precise molecular mechanisms underlying Aβ-mediated vascular alterations are not fully understood.

Purpose of the Study:

  • To elucidate the downstream pathways responsible for amyloid-beta induced cerebrovascular dysfunction.
  • To investigate the role of DNA damage and specific ion channels in Alzheimer's-related vascular pathology.

Main Methods:

  • Investigated the effects of amyloid-beta on cerebral endothelial cells.
  • Assessed DNA damage, oxidative-nitrosative stress, and poly(ADP)-ribose polymerase activation.
  • Measured intracellular calcium levels and transient receptor potential melastatin-2 (TRPM2) channel activity.

Main Results:

  • Amyloid-beta induces DNA damage via oxidative-nitrosative stress in endothelial cells.
  • Activated poly(ADP)-ribose polymerase leads to increased ADP-ribose.
  • Increased ADP-ribose opens TRPM2 channels, causing calcium overload and endothelial dysfunction.

Conclusions:

  • A novel mechanism links amyloid-beta to cerebrovascular dysfunction through DNA damage and TRPM2 channel activation.
  • TRPM2 channels represent a potential therapeutic target for Alzheimer's dementia and related neurovascular disorders.